TickerFactsScreenerDevelopers

Enveric Biosciences, Inc. (ENVB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$40.7K2011: -$30.3K2012: -$24.9K2013: -$21.6K2014: -$43.2K2015: -$3.90M2016: -$2.70M2017: -$2.74M2018: -$2.57M2019: -$647.9K2020: -$3.89M2021: -$11.46M2022: -$17.15M2023: -$14.09M2024: -$7.73M2025: -$8.14M-$8.14M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$8.14M-5.4%
2024-$7.73M+45.2%
2023-$14.09M+17.8%
2022-$17.15M-49.7%
2021-$11.46M-194.6%
2020-$3.89M-500.3%
2019-$647.9K+74.7%
2018-$2.57M+6.4%
2017-$2.74M-1.4%
2016-$2.70M+30.7%
2015-$3.90M-8941.4%
2014-$43.2K-99.5%
2013-$21.6K+12.9%
2012-$24.9K+18.1%
2011-$30.3K+25.4%
2010-$40.7K—